Management Team

Management Team

PrecisioBiotix is made up of top global scientific talent in Lysin/Phage field plus experienced Pharma/Life science entrepreneur and senior executives

  • Mark Engel


    Founded: Five successful life science companies since 1990; rich experience in new drug registrations and product commercialization

    Companies established previously: NPO Pharmaceutical (sold), Excel PharmaStudies company (sold), Tiger Medical Group (sold), Haoyisheng ("Good Doctor") (largest shareholder and director), and Phagelux AgriHealth Inc. (largest shareholder and Chairman)

    Mark established his own investment fund called Tianshi Capital that invests in life science and agricultural companies. See further

  • Dr. Bryan Li 

    EVP Medical

    Trained dermatologist (China, Korea, US)

    25 years of China and international pharmaceutical experience

    Held senior medical positions at Avon, GSK Consumer, Unilever and Sanofi

  • Dr. Assaf Raz

    VP, R&D China

    Globally recognized KOL in lysin science

    Highly published 

    Holds a number of patents in the lysin field 

    PhD from Rockefeller Univ. – Post-doc with Dr. Fischetti

  • Dr. Nancy Tawil 

    VP, CSO

    Globally recognized KOL in phages and bioengineering

    PhD in bioengineering from Ecole Polytechnique de Montreal

    Industry expert in nanotechnology, surface chemistry, polymer chemistry, and phages

  • Dr. Mya Thandar

    LysiThru Dir

    Recognized industry leader in creating novel lysins

    PhD from Rockefeller Univ. –  Post-doc with Dr. Fischetti

    Developed multiple novel patentable lysins